Serpin Pharma and HekaBio Sign Term Sheet for Groundbreaking Neuropathy Treatment
Serpin Pharma and HekaBio have signed a term sheet to develop and commercialize SP163M for preventing chemotherapy-induced peripheral neuropathy (CIPN). MANASSAS, VIRGINIA, UNITED STATES, July 8, 2024 /EINPresswire.com/ -- Serpin Pharma, a Virginia- …